학술논문

EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 17,510건 | 목록 1~20
Academic Journal
Mary K L; Department of Pharmaceutical Sciences, School of Biotechnology and Pharmaceutical Sciences, Vignan's Foundation for Science, Technology and Research, Guntur, Andhra Pradesh, India.; Podila N; Department of Pharmaceutical Sciences, School of Biotechnology and Pharmaceutical Sciences, Vignan's Foundation for Science, Technology and Research, Guntur, Andhra Pradesh, India.; Shaik AB; Department of Pharmaceutical Sciences, School of Biotechnology and Pharmaceutical Sciences, Vignan's Foundation for Science, Technology and Research, Guntur, Andhra Pradesh, India.; Chimakurthy J; Department of Pharmaceutical Sciences, School of Biotechnology and Pharmaceutical Sciences, Vignan's Foundation for Science, Technology and Research, Guntur, Andhra Pradesh, India.
Publisher: Wiley Country of Publication: England NLM ID: 8610241 Publication Model: Print Cited Medium: Internet ISSN: 1099-0801 (Electronic) Linking ISSN: 02693879 NLM ISO Abbreviation: Biomed Chromatogr Subsets: MEDLINE
Academic Journal
Ul Ain Azam N; Department of Medical Oncology, Fauji Foundation Hospital, Rawalpindi, Pakistan.; Abdus Samad F; Department of Medical Oncology, Foundation University Medical College, Pakistan.; Syed AS; Department of Radiation Oncology, Combined Military Hospital, Lahore, Pakistan.; Khan AR; Department of Medical Oncology, Life Care Hospital and research institute, Peshawar, Pakistan.; Mushtaq A; Department of Medical Oncology, Fauji Foundation Hospital, Rawalpindi, Pakistan.; Saif F; Department of Medical Oncology, Fauji Foundation Hospital, Rawalpindi, Pakistan.
Publisher: Informa Healthcare Country of Publication: England NLM ID: 101125608 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1536-0539 (Electronic) Linking ISSN: 15360288 NLM ISO Abbreviation: J Pain Palliat Care Pharmacother Subsets: MEDLINE
Academic Journal
대한한의학회지. 2024-12 45(4):71-83
Academic Journal
Su C; Alix School of Medicine - Mayo Clinic Arizona, Scottsdale, AZ, United States.; Su LL; Department of Laboratory Medicine and Pathology - Mayo Clinic Hospital, Phoenix, AZ, United States.; Gray KL; Department of Laboratory Medicine and Pathology - Mayo Clinic Hospital, Phoenix, AZ, United States.; Karlene CE; Department of Laboratory Medicine and Pathology - Mayo Clinic Hospital, Phoenix, AZ, United States.; Kinard TN; Department of Laboratory Medicine and Pathology - Mayo Clinic Hospital, Phoenix, AZ, United States.; Williams LA 3rd; Department of Laboratory Medicine and Pathology - Mayo Clinic Hospital, Phoenix, AZ, United States. Electronic address: williams.lawrence@mayo.edu.
Publisher: Pergamon Country of Publication: England NLM ID: 101095653 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-0502 (Print) Linking ISSN: 14730502 NLM ISO Abbreviation: Transfus Apher Sci Subsets: MEDLINE
Academic Journal
Lee YJ; Oncology Pharmacy, Antelope Valley Medical Offices, Kaiser Permanente, Lancaster, CA.; Delate T; Pharmacy Outcomes Research Group, Kaiser Permanente National Pharmacy, Aurora, CO.; Hui RL; Pharmacy Outcomes Research Group, Kaiser Permanente National Pharmacy, Oakland, CA.; Le K; Pharmacy Outcomes Research Group, Kaiser Permanente National Pharmacy, Downey, CA.; Pham C; Pharmacy Outcomes Research Group, Kaiser Permanente National Pharmacy, Downey, CA.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101758685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2688-1535 (Electronic) Linking ISSN: 26881527 NLM ISO Abbreviation: JCO Oncol Pract Subsets: MEDLINE
Academic Journal
Wang X; Department of Hematology, The First Hospital of Jilin University, Changchun, China.; Guo W; Department of Hematology, The First Hospital of Jilin University, Changchun, China.; Li J; Department of Hematology, The First Hospital of Jilin University, Changchun, China.; Li J; Department of Hematology, The First Hospital of Jilin University, Changchun, China.; Zhao Y; Department of Hematology, The First Hospital of Jilin University, Changchun, China.; Du B; Department of Cardiology, The Third Hospital of Jilin University, Jilin Provincial Molecular Biology Research Center for Precision Medicine of Major Cardiovascular Disease, Changchun, China.; Bai O; Department of Hematology, The First Hospital of Jilin University, Changchun, China. Electronic address: baiou@jlu.edu.cn.
Publisher: Elsevier Country of Publication: United States NLM ID: 0370506 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-2990 (Electronic) Linking ISSN: 00029629 NLM ISO Abbreviation: Am J Med Sci Subsets: MEDLINE
Report
A Phase 1 Study of Oral Cedazuridine and Decitabine Combination (ASTX727, NSC# 820631) and Filgrastim as Maintenance Therapy Post-Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
Academic Journal
최선규 (Cnh Center for Cancer Research); 박연철 (경희대학교 한의과대학 침구의학과); 성신 (소람한방병원); 김원남 (부산대학교)
대한한의학회지, Journal of Korean Medicine. 2024-12-01 45(4):71-83
Academic Journal
Shahzad M; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; H. Lee Moffitt Cancer Center, Tampa, Florida, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA.; Amin MK; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA.; Bellman P; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Al-Ramahi J; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA.; Noor J; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Vyas A; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mahmoudjafari Z; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA.; McGuirk M; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; DeJarnette S; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA.; Ahmed N; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA.; Abdallah AO; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA.; Shune L; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA.; Singh AK; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA.; McGuirk JP; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA.; Abhyankar S; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA.; Mushtaq MU; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA.
Publisher: American Association Of Blood Banks Country of Publication: United States NLM ID: 0417360 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1537-2995 (Electronic) Linking ISSN: 00411132 NLM ISO Abbreviation: Transfusion Subsets: MEDLINE
Report
Phase II Study of Horse Anti-Thymocyte Globulin (hATG), Cyclosporine, Methylprednisolone, and GCSF (Filgrastim or Pegfilgrastim) in Patients With Aplastic Anemia (AA), or Low/Int-1 Risk Myelodysplastic Syndrome (MDS)
Report
A Phase 2 Study of Fludarabine, Cytarabine, Filgrastim-sndz,Gemtuzumab Ozogamicin and Idarubicin in Newly Diagnosed Core Binding Factor Associated Acute Myelogenous Leukemia
Report
A Multicenter, Randomized, Controlled Study of Telpegfilgrastim Versus Filgrastim for Secondary Prevention of Chemotherapy-Induced Neutropenia in Children and Adolescents With Solid Tumors Receiving High-Intensity Chemotherapy Regimens
Report
Filgrastim-Mobilized Peripheral Blood Stem Cells for Allogeneic Transplantation With Unrelated Donors
Pulsipher MA, Chitphakdithai P, Logan BR, Leitman SF, Anderlini P, Klein JP, Horowitz MM, Miller JP, King RJ, Confer DL. Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34+ cell dose. Blood. 2009 Sep 24;114(13):2606-16. doi: 10.1182/blood-2009-03-208355. Epub 2009 Jul 16.
Report
A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combined With Filgrastim for Children and Young Adults With AML, MDS and Related Myeloid Malignancies
Report
A Randomized, Multicenter Pragmatic Trial Comparing Bone Pain From a Single Dose of Pegfilgrastim to 5 Doses of Daily Filgrastim in Breast Cancer Patients Receiving Neoadjuvant/Adjuvant Chemotherapy (REaCT-5G)
검색 결과 제한하기
제한된 항목
[검색어] FILGRASTIM
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어